01 13Gowling WLG (Canada) LLP
01 132527646
01 8LISDEXAMFETAMINE DIMESYLATE
02 5Lisdexamfetamine Dimesylate
01 2CAPSULE
02 5Capsule
03 6TABLET (CHEWABLE)
01 132024-06-01
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Brand Name : VYVANSE
Patent Number : 2527646
Filing Date : 2004-06-01
Strength per Unit : 60 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Brand Name : VYVANSE
Patent Number : 2527646
Filing Date : 2004-06-01
Strength per Unit : 30 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Brand Name : VYVANSE
Patent Number : 2527646
Filing Date : 2004-06-01
Strength per Unit : 50 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Brand Name : VYVANSE
Patent Number : 2527646
Filing Date : 2004-06-01
Strength per Unit : 20 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Brand Name : VYVANSE
Patent Number : 2527646
Filing Date : 2004-06-01
Strength per Unit : 40 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Brand Name : VYVANSE
Patent Number : 2527646
Filing Date : 2004-06-01
Strength per Unit : 10mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Brand Name : VYVANSE
Patent Number : 2527646
Filing Date : 2004-06-01
Strength per Unit : 70 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Brand Name : VYVANSE
Patent Number : 2527646
Filing Date : 2004-06-01
Strength per Unit : 10 mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Brand Name : VYVANSE
Patent Number : 2527646
Filing Date : 2004-06-01
Strength per Unit : 20 mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Brand Name : VYVANSE
Patent Number : 2527646
Filing Date : 2004-06-01
Strength per Unit : 30 mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-06-01
Date Granted : 2011-08-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
